Skip to main content

Reynders McVeigh Capital Management, LLC

Position in CRSP — CRISPR Therapeutics AG

CIK 1455969 BOSTON, MA

Position in CRSP

as of Mar 31, 2026 · filed Apr 27, 2026
Position Value
$5,871,945
-$238,049 QoQ
Shares Held
123,438
+5.9% QoQ
Ownership
0.128%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
21 quarters on record

Common Shares in CRSP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Reynders McVeigh Capital Management, LLC holds $30,281,607 across 2 Biotechnology names. CRSP ranks #2 (19.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 CRSP
CRISPR Therapeutics AG
This page
123,438 $5,871,945

All Filings in CRSP

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $5,871,945 123,438
2025-12-31 $6,109,994 116,514
2025-09-30 $7,323,530 113,000
2025-06-30 $5,420,003 111,431
2025-03-31 $3,463,335 101,773
2024-12-31 $3,844,960 97,687
2024-09-30 $5,618,150 119,586
2024-06-30 $6,193,488 114,673
2024-03-31 $6,610,088 96,979
2023-12-31 $5,762,204 92,048
2023-09-30 $3,457,719 76,178
2023-06-30 $2,806,887 49,998
2023-03-31 $855,027 18,904
2022-09-30 $201,604 3,085
2022-03-31 $293,763 4,680
2021-12-31 $217,109 2,865
2021-09-30 $302,211 2,700
2021-06-30 $421,723 2,605
2021-03-31 $299,751 2,460
2020-12-31 $373,588 2,440
2020-09-30 $208,263 2,490